ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,706Medicare Part D Prescriptions Filled, Including Refills

Rank: 52 out of 298

$359K Total Retail Price of All Prescriptions

Rank: 73 out of 298

421 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 421 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

9% of this provider’s 421 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 7,314 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
LEVOTHYROXINE SODIUM 399 324 1 1
OMEPRAZOLE 384 317 2 3
SIMVASTATIN 336 283 3 2
LOSARTAN POTASSIUM 303 271 4 18
LISINOPRIL 241 191 5 4
POTASSIUM CHLORIDE 239 229 6 11
HYDROCHLOROTHIAZIDE 238 214 7 13
FUROSEMIDE 235 219 8 5
METFORMIN HCL 203 159 9 10
WARFARIN SODIUM 203 194 9 7
AMLODIPINE BESYLATE 193 178 11 6
METOPROLOL SUCCINATE 178 167 12 12
ATORVASTATIN CALCIUM 142 117 13 14
PRAVASTATIN SODIUM 126 118 14 31
DIGOXIN 122 120 15 27
METOPROLOL TARTRATE 122 109 15 9
HYDROCODONE-ACETAMINOPHEN 120 85 S3 17 8
TRAMADOL HCL 113 108 18 15
GLIMEPIRIDE 110 95 19 60
LISINOPRIL-HYDROCHLOROTHIAZIDE 104 87 20 30
DOXAZOSIN MESYLATE 104 89 20 77
SPIRONOLACTONE 91 89 22 34
TAMSULOSIN HCL 90 83 23 24
SERTRALINE HCL 83 78 24 19
ATENOLOL 82 71 25 16
CITALOPRAM HBR 81 69 26 17
JANUVIA 79 53 27 73
GABAPENTIN 77 59 28 20
ALLOPURINOL 77 61 28 28
ALENDRONATE SODIUM 75 48 30 21
KLOR-CON 10 75 75 30 61
ZOLPIDEM TARTRATE 73 65 32 25
LOSARTAN-HYDROCHLOROTHIAZIDE 73 71 32 44
LABETALOL HCL 69 50 34 87
LANTUS 68 44 35 53
QUINAPRIL HCL 66 33 36 109
AMITRIPTYLINE HCL 65 54 R 37 51
ISOSORBIDE MONONITRATE ER 62 46 38 45
TRIAMTERENE-HCTZ 62 62 38 43
PAROXETINE HCL 56 46 40 48
CLOPIDOGREL 54 36 41 36
SYNTHROID 52 52 42 42
AMOXICILLIN 52 38 42 143
CIPROFLOXACIN HCL 51 51 44 56
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 6, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.